iCrowd Newswire – Jun 29, 2020
The report aims to provide a 360-degree view of the market in terms of cutting-edge technology, key developments, drivers, restraints and future trends with impact analysis of these trends on the market for short-term, mid-term and long-term during the forecast period. Further, the report also covers key players profiling with detailed SWOT analysis, financial facts and key developments of products/service from the past three years.
Thrombin is a serine protease enzyme that is encoded by a particular gene named F2 and is used to convert soluble fibrinogen into insoluble fibrin. Human thrombin is a sterile solution, having pH 6.8-7.2, containing highly purified human thrombin for the activation of clotting.
Get PDF Sample Copy of this Report @ https://www.theinsightpartners.com/sample/TIPRE00008178
It is used in various medical surgeries in the management of uncontrolled bleeding. R&D applications include several research activities such as protein-structure analysis, in vitro study, coagulation research, biochemical research, and medical research.
The human thrombin market is anticipated to rise in adoption in various research and diagnostic applications. However, the increasing hemostatic use of thrombin-based products during surgeries has driven the demand for thrombin in the hospital segment. Moreover, the growing adoption of hemostats in excessive bleeding during the surgical procedure is expected to benefit the growth of the market in the forecast period.
The human thrombin market is segmented on the basis of product, dosage form and end user. Based on product the market is segmented as bovine thrombin, human thrombin and recombinant thrombin. On the basis of dosage form the market is categorized as powder form, solution form and others. On the basis of end user the market is categorized as hospitals, diagnostics centers & clinics and academics and research institutes.
Key Players Influencing the Market:
- AMRESCO Inc.
- Baxter International, Inc.
- Bayer AG
- BD Biosciences
- CSL Behring
- Life Technologies Corporation
- Pfizer Inc.
- PromoCell GmbH
- Sigma-Aldrich Corporation
- Vitrolife AB
Request for Buy Report @ https://www.theinsightpartners.com/buy/TIPRE00008178
The Human Thrombin Market report is a combination of qualitative as well as quantitative analysis which can be broken down into 40% and 60% respectively. Market estimation and forecasts are presented in the report for the overall global market from 2018 – 2027, considering 2018 as the base year and 2018 – 2027 forecast period. Global estimation is further broken down by segments and geographies such as North America, Europe, Asia-Pacific, Middle East & Africa and South America covering major 18 countries across the mentioned regions. The qualitative contents for geographical analysis will cover market trends in each region and country which includes highlights of the key players operating in the respective region/country, PEST analysis of each region which includes political, economic, social and technological factors influencing the growth of the market.
The Insight partners,
Email: [email protected]
Keywords: Human Thrombin Market, Human Thrombin Market Size, Human Thrombin Market Growth, Human Thrombin Market Share, Human Thrombin